Zementis, Predixion Form Alliance
Bruce V. Bigelow Predixion, the Aliso Viejo, CA-based startup that recently closed on a $5 million A round led by DFJ Frontier, said it has formed a strategic partnership with Zementis, a San Diego...
View ArticleRoambi and Endeca Form Partnership
Bruce V. Bigelow Cambridge, MA-based Endeca Technologies and Del Mar, CA-based Mellmo said today they have formed a strategic partnership to share their respective technologies, which are focused on...
View ArticleTech CEO Pay Rises From 10-Year Low, Q3′s Biggest VC Deal Goes to SkinIt,...
Bruce V. Bigelow Most of last week’s technology news was about deals—funding deals and partnership deals. Get your latest update here. —San Diego’s Avalon Ventures, which has been raising its ninth...
View ArticleSG Biofuels Adds Bunge Alliance
Bruce V. Bigelow Encinitas, CA-based SG Biofuels says it has established a strategic partnership with Bunge North America to research and develop a method for processing the oil-laden seeds of the...
View ArticleRoche Ends Deal with Ligand
Bruce V. Bigelow San Diego’s Ligand Pharmaceuticals (NASDAQ: LGNDD) said today that Roche has terminated their collaboration and licensing agreement to develop a treatment for hepatitis C, according...
View ArticleGenomatica and Tate & Lyle Form Strategic Partnership as CEO Explains...
Bruce V. Bigelow The past couple of months have been busy for San Diego’s Genomatica, which is announcing a strategic partnership today with Tate & Lyle (LSE: TATE), a London-based food and...
View ArticleTVC Capital Cashes in on Accordent, GA Aeronautical Systems Delivers Last...
Bruce V. Bigelow It was relatively quiet on San Diego’s tech front last week, but the mix of news was unusual and interesting. Check it out for yourself. —San Diego-based TVC Capital, a small private...
View ArticleThe Kinsella Debate Continues over Pharma versus Biotech, Worlds in Collision
Bruce V. Bigelow Almost two months ago, Kevin Kinsella of San Diego’s Avalon Ventures, fired off some shots heard ’round the world, saying that Big Pharma’s hardball acquisition tactics and mercenary...
View ArticleLpath Looks to Raise $10 Million Through Secondary Offering
Bruce V. Bigelow San Diego’s Lpath (OTC: LPTN), a biotech developing specialized monoclonal antibodies for cancer and other diseases, intends to raise about $10 million through a secondary offering of...
View ArticleThe Thinking Behind Domain’s $760M Life Sciences Deal in Russia
Bruce V. Bigelow The partnership that the life sciences venture firm Domain Associates and the Russian state technology firm Rusnano disclosed yesterday began almost two years ago, at a time when the...
View ArticleLockheed Martin’s India Innovation Program Offers Key IP, Licensing Insights
Maxime Pinto Last Friday marked the end of the five day long DST-Lockheed Martin India Innovation Growth Program workshop (LMIIGP) that took place in Goa, India, and brought together a group of fifty...
View ArticleSan Diego Life Sciences Roundup: Optimer, CareFusion, Senomyx & More
Bruce V. Bigelow Here’s our latest roundup of news from San Diego’s life sciences community. —It took awhile, but San Diego’s Pathway Genomics appears to have recovered from the ill effects of a 2010...
View ArticleRare Disease Science Challenge Offers $400,000 in Cash & Services
Bruce V. Bigelow San Diego’s Assay Depot, which operates an online marketplace for the life sciences industry, and the nonprofit Rare Genomics Institute say they have joined with 19 life sciences...
View ArticleSapphire Energy & Institute for Systems Biology Partner on Biofuels
Bruce V. Bigelow San Diego’s Sapphire Energy and Seattle’s Institute for Systems Biology (ISB) have established a strategic partnership that is intended to significantly expand and diversify the...
View ArticleSan Diego Life Sciences Roundup: Acadia, Zogenix, Isis, & More
Bruce V. Bigelow It was a big week for news from San Diego’s public life sciences companies. We have all the deals, dollars, and developments wrapped up here. —San Diego’s Acadia Pharmaceuticals...
View ArticleLatest Venture Funding Deepens Independa’s Ties with LG Electronics
Bruce V. Bigelow Independa, the San Diego startup developing Web-based services for the elderly, says today it has closed its Series A financing at $5 million. In a telephone interview this afternoon,...
View ArticleAmbit Still Committed to Leukemia Drug After Astellas Ends Pact
Bruce V. Bigelow [Corrected 3/12/13, 11:55 pm. See below.] They say that breaking up is hard to do. Ambit Biosciences knows that it’s true. After Japan’s Astellas Pharma said last night it had...
View ArticleSan Diego Life Sciences Roundup: Ambit, Lithera, Histogen, & More
Bruce V. Bigelow Here’s our wrap up of the latest developments in San Diego’s life sciences community. —The increasing importance of emerging markets to portfolio companies of life sciences VC Domain...
View ArticleSan Diego’s Ambrx Working with Astellas to Develop Anti-Cancer Drugs
Bruce V. Bigelow San Diego-based Ambrx says it’s getting an upfront payment of $15 million under a deal with Japan’s Astellas to help develop an undisclosed number of targets for antibody drug...
View ArticleRoche & Isis Join Forces on Antisense Drug for Huntington’s Disease
Bruce V. Bigelow San Diego’s Isis Pharmaceuticals (NASDAQ: ISIS) and Roche, the Swiss Pharmaceuticals giant) have formed an alliance to develop new treatments for Huntington’s disease, according to a...
View Article